Chart of the Day: Revisiting Viking Therapeutics (VKTX)
In late August, we highlighted opportunity in oversold shares of Viking Therapeutics (VKTX), as it traded at $26.62. We noted, “Over the last few weeks, VKTX plummeted from about $40 to $26.05. All after the company posted mid-stage trial data on its obesity pill that...










